跳至主要内容
临床试验/NCT00825513
NCT00825513已完成4 期

Monocular Study to Evaluate the Safety and Effectiveness of the Akreos™ Toric IOL When Used to Correct Primary Aphakia With the Reduction of Astigmatism

Bausch & Lomb Incorporated2 个研究点 分布在 1 个国家目标入组 198 人开始时间: 2009年2月最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
198
试验地点
2
主要终点
Reduction of cylinder, Lens axis misalignment as determined by a photographic method.

研究概览

简要总结

The purpose of this study is to evaluate the safety and effectiveness of the Akreos Toric IOL following cataract surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects must be willing and able to provide written consent on the EC approved Informed Consent form.
  • Subjects must require a lens power from 15 to 30 diopters.

排除标准

  • Subjects with any anterior segment pathology for which extracapsular phacoemulsification cataract surgery would be contraindicated.
  • Subjects with corneal pathology potentially affecting topography.

研究组 & 干预措施

Akreos Advanced

Active Comparator

Akreos Advanced Optics Aspheric Intraocular Lens (Akreos AO)

干预措施: Akreos Advanced Optics Aspheric Intraocular Lens (Akreos AO) (Device)

Akreos Toric

Experimental

Akreos Toric Intraocular Lens

干预措施: Akreos Toric IOL (Device)

结局指标

主要结局

Reduction of cylinder, Lens axis misalignment as determined by a photographic method.

时间窗: 32 months

次要结局

  • Lens misalignment as determined by postoperative manifest refraction and vector analysis.(32 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验